, and LSC deficiency is a major cause of blindness worldwide 4 . Transplantation is often the only therapeutic option available to patients with LSC deficiency. However, while transplant success depends foremost on LSC frequency within grafts 5 , a gene allowing for prospective LSC enrichment has not been identified so far 5 . Here we show that ATP-binding cassette, sub-family B, member 5 (ABCB5) 6,7 marks LSCs and is required for LSC maintenance, corneal development and repair. Furthermore, we demonstrate that prospectively isolated human or murine ABCB5-positive LSCs possess the exclusive capacity to fully restore the cornea upon grafting to LSCdeficient mice in xenogeneic or syngeneic transplantation models. ABCB5 is preferentially expressed on label-retaining LSCs 2 in mice and p63a-positive LSCs 8 in humans. Consistent with these findings, ABCB5-positive LSC frequency is reduced in LSC-deficient patients. Abcb5 loss of function in Abcb5 knockout mice causes depletion of quiescent LSCs due to enhanced proliferation and apoptosis, and results in defective corneal differentiation and wound healing. Our results from gene knockout studies, LSC tracing and transplantation models, as well as phenotypic and functional analyses of human biopsy specimens, provide converging lines of evidence that ABCB5 identifies mammalian LSCs. Identification and prospective isolation of molecularly defined LSCs with essential functions in corneal development and repair has important implications for the treatment of corneal disease, particularly corneal blindness due to LSC deficiency.
ABCB5, first identified as a marker of skin progenitor cells 6 and melanoma stem cells 7, 9 , functions as a regulator of cellular differentiation 6 . On the basis of this function and its expression on stem cells in additional organ systems 10 , we hypothesized that ABCB5 might also identify slowcycling, label-retaining LSCs in the eye. We performed bromodeoxyuridine (BrdU)-based 'pulse-chase' experiments (Extended Data Fig. 1a ) in Abcb5 wild-type mice, which revealed 8-week label-retaining cells only in the limbus, but not central cornea ( 1 cells (range 0.4-2.3%) were predominantly BrdU-positive (75.7 6 7.5%), in contrast to Abcb5 2 cells (3.3 6 2.3%, P , 0.001) (Fig. 1d ). Similar to findings in mice (Figs 1c, 2d, e and Extended Data Fig. 3a, b) , human ABCB5 1 cells were also located in basal limbal epithelium (Fig. 1e) . Moreover, they localized to the palisades of Vogt ( LSCs, determined using distinct DNp63a antibodies (DNp63a/TAp63a epitope positivity in ABCB5 1 versus ABCB5 2 cells: 28.9 6 5.7% versus 0.16 0.1%; DNp63a,b,c epitope positivity: 28.96 14.7% versus 0.1 6 0.1%; P , 0.05) (Fig. 1f) and did not express the differentiation marker keratin 12 (KRT12) (Fig. 1g) . Moreover, limbal biopsies from LSC-deficient (LSCD) patients exhibited reduced ABCB5
1 frequencies compared to controls (2.8 6 1.6% versus 20.0 6 2.6%, P , 0.001) ( Fig. 1h and Extended Data Fig. 2 ). ABCB5 expression on label-retaining LSCs in mice and p63a
1 LSCs in humans, along with reduced ABCB5 1 frequency in clinical LSCD, showed that ABCB5 preferentially marks LSCs.
To investigate Abcb5 function in corneal development and regeneration, we generated Abcb5 knockout mice lacking exon 10 of the murine gene (GenBank accession number JQ655148), which encodes a functionally critical extracellular domain homologous to amino acids 493-508 of human ABCB5 (ref. 6) (GenBank accession number NM_178559) (Fig. 2a, b) . Polymerase chain reaction (PCR) analysis confirmed deletion (Fig. 2c) . Abcb5 protein loss was demonstrated using an exon-10-encoded epitope-targeted monoclonal antibody (Fig. 2c) , an amino-terminustargeted antibody (Extended Data Fig. 3c) , and a specific extracellular-loopassociated peptide-targeted human immunoglobulin (Ig)G1 monoclonal antibody (clone 3B9) ( Fig. 2d and Extended Data Fig. 3a) . Wild-type tissues only expressed Abcb5 in the limbus but not the cornea ( Abcb5 knockout mice were indistinguishable by physical examination from wild-type littermates through adulthood and their eyes contained all anterior and posterior segment components ( Fig. 2f and Extended Data Fig. 3d ). However, histological analysis of mutant versus wild-type corneas demonstrated developmental abnormalities characterized by decreased cellularity of the apical epithelial layer and disorganized basal and wing cell layers ( Fig. 2f and Extended Data Fig. 3e ). No inflammation was noted (Extended Data Fig. 3f ). Reduced epithelial cell numbers in the central cornea but not limbus of knockout versus wildtype mice were confirmed by histological enumeration (cornea: 2,688 6 399 versus 4,427 6 346 cells, P , 0.05; limbus: 3,015 6 433 versus 3,629 6 94 cells, P 5 not significant) (Fig. 2g ) and flow cytometry (Extended Data  Fig. 3g ). Corneas in knockout mice also exhibited epithelial tight junction defects ( Fig. 2h ) and increased fragility versus wild-type corneas (brush injury frequency 100% versus 33%, P , 0.001) (Extended Data Fig. 4a ). Moreover, knockout versus wild-type mice showed reduced limbal and corneal Pax6 and corneal Krt12 expression (limbal Pax6: 0.3 6 0.3% versus 18.0 6 4.6%; corneal Pax6: 8.3 6 4.6% versus 42.0 6 7.6%; corneal Krt12: 6.5 6 6.5% versus 47.7 6 8.2%; P , 0.05) (Fig. 2h and Extended Data Fig. 3h ), also demonstrating an essential role of Abcb5 in corneal development. Additional ocular abnormalities involved the retina (Extended Data Fig. 5 ), where ABCB5 is also expressed 11 .
Restoring the corneal epithelium after wounding is a hallmark function of LSCs. To determine whether wound healing requires Abcb5, knockout and wild-type mice received central corneal epithelial debridement injuries (Extended Data Fig. 4b-d ). Wound closure rates were not significantly different (Extended Data Fig. 4e) ; however, knockout mice exhibited abnormal corneal restoration characterized by irregular epithelium with reduced cell numbers (403 6 30 versus 737 6 28, P , 0.001) ( Fig. 2i and Extended Data Fig. 4f ), increased cellular proliferation (Ki67 limbus: 54.06 5.0% versus 0.36 0.2%, P , 0.001; cornea: 41.06 14.0% versus 7.5 6 2.4%, P , 0.05) (Fig. 2j) , and increased apoptosis (limbus: 41.2 6 12.8% versus 1.0 6 0.5%; cornea: 49.0 6 10.0% versus 0.4 6 0.3%; P , 0.001) ( Fig. 2k and Extended Data Fig. 4g ).
On the basis of our finding that Abcb5 preferentially identifies labelretaining and p63a
1 LSCs, we hypothesized that Abcb5 was required for LSC maintenance. We therefore examined quiescent LSCs in knockout versus wild-type mice, using the BrdU-labelling approach (Extended Data Fig. 1a, b) . After a 24 h chase, epithelial cells were equally labelled in knockout versus wild-type specimens (5.7 6 0.9% versus 7.2 6 1.0%, P 5 not significant) (Extended Data Fig. 6b ). In contrast, after an 8-week chase, label-retaining LSC frequency was reduced in knockout versus wild-type mice (0.1 6 0.1% versus 0.9 6 0.3%, P , 0.05) (Extended Data Fig. 6a ). Histological examination of limbal epithelium confirmed selective loss of BrdU label-retaining cells in knockout versus wild-type mice (Extended Data Fig. 6c, d and Supplementary Video 2), demonstrating that abrogation of Abcb5 function induces LSC proliferation. Consistent with this result, Ki67 expression was enhanced in knockout versus wildtype tissues (limbus: 24.0 6 5.0% versus 1.5 6 1.5%, P , 0.001; cornea: 53.06 16.0% versus 11.06 2.1%, P , 0.05) (Extended Data Fig. 6e ). Because cell cycle withdrawal is a prerequisite for LSC maintenance and hence normal differentiation, these results provided one explanation for the corneal differentiation defect in knockout mice. Moreover, impaired cell cycle withdrawal was associated with enhanced apoptosis, demonstrating a novel anti-apoptotic role of Abcb5. Consistent with this function, ABCB5 monoclonal antibody treatment of p63a-rich human limbal epithelial cells, using blocking concentrations 12 , induced apoptosis in 30.9 6 2.9% of cells versus controls (P , 0.001), commensurate with ABCB5 expression levels (Extended Data Fig. 6f, g ). Moreover, ABCB5 blockade induced pro-apoptotic p53(S15) and p53(S392) and downregulated anti-apoptotic Bcl2 and Bcl-x (also known as Bcl2l1) (Extended Data Fig. 6h, i) . In contrast, non-blocking monoclonal antibodies concentrations employed for cell sorting (2 mg ml
21
) maintained viability at .90%.
Clinical studies in LSCD have shown that LSC frequency within grafts is critical for long-term transplant success 5 . To investigate whether ABCB5 represents a marker for prospective LSC enrichment, we examined the cornea-regenerative potential of transplanted murine or human 104   103   102   101   100  0 200  600  1,000   104   103   102   101   100  0 200  600  1,000   104   103   102   101   100  0 200  600  1,000   104   103   102   101   100  0 200  600  1,000   104   103   102   101   100  100  101  102  103  104   104   103   102   101   100  100  101  102  103  104  100  101  102  103  104   104   103   102   101   100   104   103   102   101   100   104   103   102   101   100  100  101  102  103  104  100  101  102  103  104   104   103   102   101   100   104   103   102   101   100   104   103   102   101   100  0 1,000 0 1,000 0 1,000 Quantitative analysis of ABCB5 expression in n 5 2 control and n 5 2 LSCD specimens was performed using n 5 8 sections per patient/control. All epithelial cells were counted in each section. A total of 2,031 and 2,051 epithelial cells were counted in patient 1 and donor 1, respectively. A total of 563 and 2,662 epithelial cells were counted in patient 2 and donor 2, respectively. Data were analysed using the unpaired t-test. Error bars indicate s.e.m. *P , 0.05, ***P , 0.001.
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1 or ABCB5 2 limbal cells in syngeneic or immunodeficient NSG mice with induced LSCD (Extended Data Fig. 7) . Recipients of syngeneic murine Abcb5 2 grafts or vehicle-only negative controls displayed opaque corneas, epithelial conjunctivalization and absence of differentiated Krt12 1 cells (0%, in both cases) when analysed 5 weeks after transplantation, consistent with persistent LSCD (Fig. 3a and Extended Data Fig. 8a, b) . Recipients of syngeneic unsegregated grafts displayed partial corneal restoration with differentiated Krt12 1 cells in the central cornea (17%, enhanced versus Abcb5 2 or vehicle-only treatment, P , 0.01), but exhibited persistence of LSCDcharacteristic epithelial conjunctivalization ( Fig. 3a and Extended Data Fig. 8a, b) . In contrast, syngeneic Abcb5 1 grafts resulted in the development of clear corneas with normal histology, gave rise to more differentiated Krt12 1 cells (47%, increased versus unsegregated or Abcb5 2 cell treatment or vehicle-only controls, P , 0.001) and prevented epithelial conjunctivalization ( Fig. 3a and Extended Data Fig. 8a, b) . NSG recipients of human ABCB5 2 grafts or vehicle-only controls also displayed epithelial conjunctivalization and an absence of differentiated KRT12
1 cells (0%, in both cases) 5 weeks after transplantation ( Fig. 3b  and Extended Data Fig. 8c ). NSG recipients of human unsegregated grafts displayed partial corneal restoration with differentiated KRT12 1 cells in the central cornea (12%, enhanced versus ABCB5 2 or vehicle-only treatment, P , 0.01), but exhibited persistence of LSCD-characteristic epithelial conjunctivalization ( Fig. 3b and Extended Data Fig. 8c ). Strikingly, only human ABCB5 1 grafts, negative for KRT12 before transplantation (Extended Data Fig. 7g ), produced clear corneas with normal histology and high numbers of KRT12 1 cells (31%, increased versus vehicle-only or versus ABCB5
2 or unsegregated limbal cell treatment, P , 0.001) and an absence of LSCD-characteristic epithelial conjunctivalization ( Fig. 3b and Extended Data Fig. 8c ). To confirm that human donor cells caused corneal restoration, we assayed regenerated corneal tissue by PCR with reverse transcription (RT-PCR) for human-specific b2 microglobulin (b2M), an identifier of all human cells, and human-specific PAX6 and KRT12 as markers of corneal differentiation. Only corneal epithelium of recipients grafted with ABCB5 1 or unsegregated human limbal cells contained human-specific b2M, PAX6 and KRT12 transcripts, whereas vehicle-only-grafted control eyes that did not exhibit corneal restoration did not, confirming human specificity of the RT-PCR assay (Fig. 3b) . Moreover, despite similar viability in ABCB5
2 compared with unsegregated or ABCB5
1 cell grafts (Extended Data Fig. 7e , f, h), ABCB5 . f-h, Slit lamp and haematoxylin and eosin (H&E; 340 magnification) (f), cellularity (g) and LC-biotin diffusion and protein expression (h) analyses. i, Analysis of wild-type and knockout corneas following debridement wounding. j, k, Ki67 immunofluorescence (j) and TdT-mediated dUTP nick end labelling (TUNEL) (k) staining. g-k, 320 magnification. g, The numbers of viable epithelial cells in Abcb5 knockout versus Abcb5 wild-type murine central cornea were derived from the analysis of n 5 8 mice per group (left bar graph). The experiment was performed four times. Data were analysed using the unpaired t-test. Data are shown as mean 6 s.e.m., P , 0.05. In the right bar graph, the numbers of viable epithelial cells in Abcb5 knockout versus Abcb5 wild-type murine limbus were derived from the analysis of n 5 6 mice per group. The experiment was performed three times. Data were analysed using the unpaired t-test. Data are shown as mean 6 s.e.m., P 5 not significant. h, Quantitative analyses of Pax6 expression in limbus and cornea of Abcb5 knockout versus Abcb5 wild-type mice were performed using n 5 3 mice per group. The experiment was performed three times. Ten thousand cells per experiment were counted for each group. Data were analysed using the unpaired t-test. Data are shown as mean 6 s.e.m., P , 0.05. Quantitative analyses of Krt12 expression in cornea were performed using n 5 2 mice per group. The experiment was performed twice. Ten thousand cells per experiment were counted for each group. Data were analysed using the unpaired t-test. Data are shown as mean 6 s.e.m., P , 0.05. i, The numbers of DAPI 1 cells per section in Abcb5 wild-type versus Abcb5 knockout mice (mean 6 s.e.m.) were derived from n 5 6 mice per group. The experiment was performed twice. Within the standardized area (shown in Extended Data Fig. 4f ), all corneal epithelial cells were counted in at least n 5 3 consecutive composite cross-sections. Data were analysed using the unpaired t-test, P , 0.001. j, The percentages of Ki67 1 epithelial cells in limbus and cornea of Abcb5 knockout versus Abcb5 wild-type mice (mean 6 s.e.m.) were determined using n 5 4 mice per group. The experiment was performed twice. Within a standardized area, all limbal epithelial cells were counted in at least n 5 3 consecutive cross-sections. Data were analysed using the unpaired t-test, P , 0.001 for limbus and P , 0.05 for cornea. k, The percentages of TUNEL 1 epithelial cells in limbus or cornea of Abcb5 knockout versus Abcb5 wild-type mice (mean 6 s.e.m.) were determined using n 5 4 mice per group. The experiment was performed twice. Within a standardized area, all limbal epithelial cells were counted in at least n 5 3 consecutive cross-sections. Data were analysed using the unpaired t-test, P , 0.001 for limbus and P , 0.001 for cornea. Error bars indicate s.e.m. *P , 0.05, ***P , 0.001. NS, not significant.
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eyes were deficient in human-specific b2M, PAX6 or KRT12 expression (Fig. 3b) , indicating that engraftment capacity was exclusively contained within the ABCB5 1 cell population. To further confirm LSC function of ABCB5 1 limbal cells, we evaluated their capacity for long-term (.1 year) corneal restoration. LSCD-NSG recipients of human ABCB5 2 grafts or vehicle-only controls, 13 months after transplantation, continued to display epithelial conjunctivalization, reduced epithelial thickness and increased stromal thickness with an absence of differentiated KRT12 1 cells (0%, in both cases), consistent with persistent LSCD (Fig. 3c and Extended Data Figs 9, 10). NSG recipients of human unsegregated grafts displayed partial corneal restoration withdifferentiatedKRT12
1 cells inthecentralcornea (37%,enhanced versus ABCB5
2 or vehicle-only treatment, P , 0.001), but exhibited persistence of LSCD characterized by lower-than-normal epithelial thickness and higher-than-normal stromal thickness ( Fig. 3c and Extended Data Figs 9, 10). In contrast, only purified human ABCB5
1 grafts produced clear corneas with normal histology in recipient NSG mice, with the presence of a stratified epithelial layer containing high numbers of KRT12 1 cells (88%, increased versus vehicle-only or versus ABCB5 2 or unsegregated limbal cell treatment, P , 0.001) and the absence of LSCDcharacteristic epithelial conjunctivalization, accompanied by restoration of normal epithelial and stromal thickness ( Fig. 3c and Extended Data Figs 9, 10) and specific detection of human KRT12
1 corneal cells (pixel intensity per unit area: 42.3 6 7.7 versus 4.3 6 0.7, respectively, P , 0.01) ( Fig. 3d and Extended Data Fig. 9c ).
Our findings that ABCB5 1 cell frequency is reduced in LSCD, that ABCB5-positivity preferentially characterizes slow-cycling and p63a-positive populations, and that prospectively isolated ABCB5 1 limbal cells are exclusively capable of reversing LSCD through long-term corneal regeneration show that ABCB5-positivity defines LSCs. This result is further supported by our demonstration that Abcb5 knockout mice have impaired LSC-dependent corneal development and wound healing through deficient LSC maintenance due to deregulated antiapoptotic signals. These results have several important implications. First, successful enrichment of human LSCs has the potential to decisively advance the field of LSCD therapy, because long-term clinical success depends on LSC frequency within grafts 5 and because, thus far, no marker for prospective enrichment of bona fide LSCs defined by long-term corneal restorative capacity has been available 13 . Indeed, our study provides initial proof-of-principle for the hypothesis that prospective LSC enrichment within grafts can markedly enhance LSCD therapeutic success. What makes ABCB5 very useful and unique among LSC genes is its expression on the LSC surface, allowing for monoclonalantibody-based LSC sorting strategies and enrichment as demonstrated in our study, in contrast to intracellularly expressed p63a and alternative candidate LSC-associated genes that have as of yet not been successfully employed for prospective isolation of human LSCs capable of in vivo LSCD reversal. This underscores the promise of ABCB5 as a marker for LSC isolation for clinical transplantation. Second, our study reveals a novel in vivo physiological function of ABCB5 in maintaining quiescent LSCs, through ABCB5-dependent regulation of apoptotic signalling pathways. This parallels the known anti-apoptotic function of the ABCB5 1 human grafts at 13 months. Magnification: columns 2 and 4: 320; column 3: 340. Scale bars: 100 mm. The transplantation experiments shown in a and b were performed in n 5 5 mice per group. The experiment was performed twice. For KRT12 expression analyses, all corneal epithelial cells within a standardized area (Extended Data Fig. 8b) were counted in at least n 5 3 consecutive cross-sections from n 5 4 replicate mice per group. Data were analysed using the one-way ANOVA and Bonferroni multiple comparisons tests. Data are shown as mean 6 s.e.m. c, The transplantation experiments were performed in n 5 5 mice per group. The experiment was performed twice. For KRT12 expression analyses, all corneal epithelial cells within a standardized area (Extended Data Fig. 9b) were counted in at least n 5 3 consecutive cross-sections from n 5 4 replicate mice per group. Data were analysed using the one-way ANOVA and Bonferroni multiple comparisons tests. Data are shown as mean 6 s.e.m. d, Human KRT12 expression was analysed in n 5 4 mice per group. Within a standardized area (Extended Data Fig. 9b ), all corneal epithelial cells were counted in at least n 5 3 consecutive cross-sections. Data were analysed using the unpaired t-test. Data are shown as mean 6 s.e.m. Error bars indicate s.e.m. **P , 0.01, ***P , 0.001. ND, not detected; NS, not significant.
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homologue ABCB1, shown to be mediated through cross-talk with Bcl-x 14 . Finally, our finding that ABCB5 regulates stem cell maintenance is highly relevant to the study of additional ABCB5-expressing normal stem cell populations in other tissues 6,10 and of slow-cycling ABCB5 1 cancer stem cells, in which this role might represent one mechanism of multidrug resistance to cell-cycle-specific agents 10,11,15
. The herein described creation of a novel Abcb5 gene knockout model represents a critical step towards such studies and to further dissection of ABCB5 gene function in many relevant normal and cancerous tissues.
METHODS SUMMARY
Commercially available mouse strains and Abcb5 knockout mice were maintained in accordance with the Institutional Guidelines of Boston Children's Hospital and the Schepens Eye Research Institute, Harvard Medical School. Human corneoscleral tissues derived from consented donors according to Institutional Review Board (IRB)-approved protocols were obtained from Heartland Lions Eye Banks, the Bascom Palmer Eye Institute and the Carver College of Medicine.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. /SzJ (NSG), B6;SJL-Tg(ACTFLPe)9205Dym/J and B6.FVB-Tg(EIIa-cre)C5379Lmgd/J mice were purchased from Jackson Laboratory. Abcb5 knockout mice were generated as described later. All animals were maintained in accordance with the Institutional Guidelines of the Boston Children's Hospital and the Schepens Eye Research Institute, Harvard Medical School. Four-to-twelve-week-old mice were used for the experiments. Generation of a germline Abcb5 knockout mouse. We generated a conditional knockout construct by inserting two loxP sites flanking murine Abcb5 exon 10 (GenBank accession number JQ655148) (Fig. 2a, b) . A targeting construct was generated by recombineering 16 . In brief, a neomycin resistance cassette flanked by two loxP sites (based on plasmid pL-452) was inserted into the BAC clone RP23-161L22 458 base pairs upstream of exon 10 of the murine Abcb5 gene (GenBank accession number JQ655148). The targeted region of the BAC clone was retrieved by gap repair into the pL-253 plasmid. The retrieved plasmid contained 6,006 bp upstream of exon 10 (not including the inserted neo cassette) and 6,384 bp downstream of exon 10. The neomycin resistance cassette was excised by arabinose induction of Cre recombinase to leave a single loxP site upstream of exon 10. A neomycin resistance cassette flanked by two FRT sites and one loxP site (based on plasmid pL-451) was inserted 460 bp downstream of exon 10 to complete the targeting construct. The targeting plasmid was verified by DNA sequencing and restriction mapping. The linearized plasmid was transfected into TC1 (129S6/SvEvTac derived) embryonic stem (ES) cells and selected in G418 (Sigma-Aldrich) and Fialuridine (Moravek Biochemicals). Resistant colonies were expanded and screened by long-range PCR to identify targeted clones. The left arm was amplified with 59-GTTGAGGGGAGCAGCCAGAGCAAGGTGAGAAAGGTG-39 and 59-TTAAGGGTTATTGAATATGATCGGAATTGGGCTGCAGGAATT-39 primers yielding a 6,250 bp PCR product (Fig. 2b) . The right arm was amplified with 59-TG GGGCAGGACAGCAAGGGGGAGGAT-39 and 59-CTGGTCCCTCTCCTGTG ATCTACACAGGCC-39 primers yielding a 6,384 bp PCR product (Fig. 2b) . Two Abcb5-targeted ES clones were identified. These clones were expanded and injected into C57BL/6 blastocysts that were then transferred to the uterus of pseudopregnant females. High-percentage chimaeric male mice (Abcb5 neo-loxP/wt ) were bred into a C57BL/6 background to obtain germline transmission. Germline transmission of the Abcb5 neo-loxP allele was confirmed by PCR analysis of genomic DNA using 59-GGAAGACAATAGCAGGCATGCTGGG-39, 59-GGCTGGGGCAACTGAAAA GTAGCAT-39, and 59-TTTCAGCTTCAGTTTATCACAATGTGGGTT-39 primers designed to amplify the 385 bp targeted allele and the 284 bp wild-type allele. Heterozygous Abcb5 neo-loxP mice were then intercrossed with hACTB-FLPe transgenic mice 17 to remove the neomycin resistance cassette. PCR analysis of genomic DNA was performed to confirm removal of the neomycin resistance cassette in the genome of ABCB5 loxP/wt mice using 59-ACTTGGTGCGGTGACTCTGAATTTT GC-39 and 59-TAGCAACATTTCTGGCATTTTAGGCTG-39 primers designed to amplify a 494 bp neomycin resistance cassette-deleted allele and a 390 bp wild-type allele. To determine the outcome of a complete loss of ABCB5 function, exon 10 of the murine Abcb5 gene was deleted by breeding Abcb5 loxP mice with EIIa-Cre mice, which express Cre recombinase at the zygote stage 18, 19 (Fig. 2b) . Deletion of the genomic region between the two loxP sites was confirmed by PCR analysis of genomic DNA using 59-GGCTGGGGCAACTGAAAAGTAGCAT-39, 59-GCAAA TGTGTACTCTGCGCTTATTTAATG-39 and 59-TGGTGCAGACTACAGACG TCAGTGG-39 primers designed to amplify a 322 bp cre-deleted allele (null) and a 113 bp wild-type (WT) allele (Fig. 2c) . Heterozygous Abcb5 null/WT mice with the germline deletion of exon 10 were intercrossed to produce homozygous Abcb5 null/null (Abcb5 knockout) mutants. Mice were maintained on a 129S6/SvEvTac/C57BL/6 mixed genetic background and littermates were used as controls for experimental analyses. Western blot analysis and human apoptosis array. Abcb5 wild-type and Abcb5 knockout cell lysates were immunoblotted using monoclonal ABCB5 antibody 3C2-1D12 (ref. 6) (5.5 mg ml 21 ), a rabbit polyclonal N-terminus-targeted ABCB5 antibody (1:100 dilution) (Abgent), or an a-tubulin rabbit polyclonal antibody (1:5,000 dilution) (Abcam). A human apoptosis proteome profiler antibody array (R1D Systems) was used according to the manufacturer's instructions, using 400 mg human limbal epithelial cell lysates prepared from cells treated for 48 h with either blocking concentrations 12 of anti-ABCB5 monoclonal antibody clone 3C2-1D12 (ref. 6) or equivalent concentrations of isotype control monoclonal antibody (clone MOPC31C, Sigma). The pixel densities of array spots were quantified using ImageJ software. RT-PCR. For detection of human-specific gene transcripts, total RNA was isolated from transplanted murine eyes and non-injured murine or human control corneas using the RNAeasy Plus isolation kit (Qiagen) and then transcribed using the High Fidelity RT kit (Applied Biosystems). PCR was performed using Taq 2X Master Mix (New England Biolabs) and the following gene-specific primers.
Human b2-microglobulin (B2M, NM_004048): forward 59-GTGTCTGGGTT TCATCCATC-39, reverse 59-AATGCGGCATCTTCAACCTC-39; human paired box 6 (PAX6, NM_000280.3): forward 59-CAGCGCTCTGCCGCCTAT-39, reverse 59-CATGACCAACACAGATCAAACATCC-39; human keratin 12 (KRT12, NM_ 000223.3): forward 59-GAAGCCGAGGGCGATTACTG-39, reverse 59-GTGCTTG TGATTTGGAGTCTGTCAC-39; and murine b-actin (Actb, NM_007393): forward 59-TCCTAGCACCATGAAGATC-39, reverse 59-AAACGCAGCTCAGTAACA G-39. RNA in situ hybridization. Abcb5 RNA probes were prepared as follows. PCRderived RNA probe templates were synthesized by introducing the T7 promoter into the antisense strand and the SP6 promoter into the sense strand. The primer pair (59-TAATACGACTCACTATAGGGACCATATGCAATGGCGGTAAAG-39 and 59-GATTTAGGTGACACTATAGAGACACTTCAGACTCAACACAG-39) was used to generate the DNA template for antisense and sense RNA probes spanning 144 bp of murine Abcb5 complementary DNA containing exon 10 (GenBank accession number JQ655148). RNA probe labelling with digoxigenin (DIG) and in situ hybridizations were carried out as described previously 20 . BrdU pulse and chase experiments. Four-week-old Abcb5 knockout mice and their wild-type littermates were subjected to daily intraperitoneal injections of 50 mg kg 21 BrdU (BD Pharmingen) for 9 consecutive days (Extended Data Fig. 1a ). Limbal and central corneal epithelial cells were harvested from Abcb5 wild-type and Abcb5 knockout mice either 24 h or 8 weeks after receiving the last BrdU injection. Limbal and central corneal epithelial cells were also harvested from agematched untreated Abcb5 wild-type and Abcb5 knockout mice for use as experimental controls. Flow cytometry and immunohistochemistry staining were used to determine the frequency of BrdU-positive and BrdU-negative cells within epithelia of the limbus and central cornea. The threshold for BrdU positivity in the pulse chase experiments was determined using the background levels obtained from anti-BrdU antibody-stained limbal or corneal epithelial cells from either wild-type or Abcb5 knockout mice that did not receive any prior BrdU injections. These thresholds were used to establish the BrdU-positive gates shown in Extended Data Fig. 6a . An example of the controls used to set gates for BrdU positivity is shown in Extended Data Fig. 1b . Human and murine corneal cell isolation. Cadaveric human corneoscleral tissues derived from consented donors according to Institutional Review Board (IRB)-approved protocols were obtained from Heartland Lions Eye Banks, Bascom Palmer Eye Institute, and Carver College of Medicine. After removal of the scleral rim, iris and trabecular meshwork, the limbus and central cornea were dissected under a microscope. Limbal and central corneal tissues were subsequently incubated with 2.4 units ml 21 Dispase II (Roche Diagnostics) at 37 uC for 1 h, followed by incubation with 0.5 M EDTA (Invitrogen) at 37 uC to recover the epithelial cells 21, 22 . Murine limbal and corneal epithelial cells were obtained from Abcb5 knockout and Abcb5 wild-type mice. Immediately after euthanasia by CO 2 narcosis and subsequent eye enucleation, limbal and central corneal tissues were removed with microscissors under a dissecting microscope, placed in low Ca 21 keratinocyte serum free medium (KSFM, Invitrogen) and centrifuged for 5 min at 250g at 4 uC. After removal of the supernatant, tissue pellets were digested in 0.5% trypsin solution (Lonza) 23 
. For transplantation experiments, ABCB5
1 and ABCB5 2 limbal epithelial cells were isolated by FACS using ABCB5 monoclonal antibody labelling 11 . In brief, either human or murine limbal epithelial cells were labelled with primary ABCB5 monoclonal antibody (20 mg ml 2 sorted cells were established in representative post-sort analyses in which samples were re-analysed (Extended Data Fig. 7 ). ABCB5
1 cell purification resulted in a 255-fold increase for murine ABCB5 1 limbal cells (0.37% positivity before and 51% positivity after sorting; Extended Data Fig. 7h ) and a 292-fold increase for human ABCB5
1 limbal cells (0.03% positivity before and 59% positivity after sorting; Extended Data Fig. 7h ). ABCB5
2 cell enrichment resulted in complete absence of ABCB5 1 cells in both mouse and human samples (Extended Data Fig. 7h ). Primary culture-expanded p63a-rich limbal epithelial cells for use in ABCB5 inhibition studies were purchased from Invitrogen (catalogue no. C-018-5C). Flow cytometric analysis. Dual-colour flow cytometry was used to determine whether human ABCB5
1 limbal epithelial cells co-expressed p63a or KRT12 and whether murine Abcb5 1 limbal epithelial cells co-expressed Pax6 and Krt12, and was performed as described previously 11 . For human and murine ABCB5 and KRT12 coexpression analysis, cells were first incubated with mouse anti-ABCB5 monoclonal antibody, counterstained with goat anti-mouse FITC IgG, followed by incubation
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with goat polyclonal anti-KRT12 antibody and counterstaining with Dylight 649 donkey anti-goat IgG. For human ABCB5 and p63a co-expression and murine Abcb5 and Pax6 co-expression analysis, cells were incubated with mouse anti-ABCB5 monoclonal antibody, counterstained with goat anti-mouse FITC IgG, permeabilized in BD Cytofix/Cytoperm Buffer (BD Biosciences), stained with either p63a or Pax6 antibodies, and counterstained with goat anti-rabbit Alexa 647 IgG. Washing steps with staining buffer or BD Perm/Wash Buffer (BD Biosciences) were performed between each step. Dual-colour flow cytometry was performed by acquisition of fluorescence emission at the Fl1 (FITC) and Fl4 (Alexa 647 and/ or Dylight 649) spectra on a Becton Dickinson FACScan (Becton Dickinson), as described 11 . Murine Abcb5 and BrdU co-expression analysis was performed using the FITC BrdU Flow Kit (BD Biosciences), according to the manufacturer's instructions. Statistical differences between expression levels of the above-listed markers by ABCB5 1 and ABCB5 2 cells were determined using the unpaired t-test. A two-sided P value of P , 0.05 was considered significant. For determination of the epithelial cell numbers in the central cornea and limbus of Abcb5 wild-type and Abcb5 knockout mice, dissociated single cell suspensions were stained with DAPI (1 mg ml 21 DAPI, Sigma-Aldrich) and analysed by flow cytometry using forward-scattered light (FSC) versus side-scattered light (SSC) to identify viable cells. Statistical differences between Abcb5 wild-type and Abcb5 knockout mice were determined using the unpaired t-test. A two-sided P value of P , 0.05 was considered significant. Histopathology and immunohistochemical staining. To recover intact mouse ocular tissue, the whole decapitated mouse head was fixed in 4% PFA overnight, then eyes were enucleated with the lids attached, incubated in 30% sucrose in 13PBS overnight at 4 uC, embedded in Tissue-Tek OCT compound (Sakura Finetek USA) and snap-frozen. Representative cryostat sections from each tissue block were stained with H&E. For immunofluoresence staining, cryostat sections (10 mm) were fixed in cold methanol for 10 min, blocked in 10% secondary serum plus 2% BSA in 13 PBS for 1 h, incubated with the primary antibody (or isotype control), followed by the appropriate secondary antibody for 1 h at room temperature. Following several washes, the slides were then coverslipped in hard-set mounting media with DAPI. Composite corneal photographs were assembled using Photoshop (Adobe) to overlay and match sequential images. Stitching was done by reducing the added photograph to 50% transparency, matching images, and returning the composite photograph to 0% transparency. The average number of epithelial cells per cornea (Fig. 2g) was determined by counting the number of DAPI-positive cells within the area defined by a 2 mm trephine in a composite photograph of a complete corneal section. At least three composite corneal sections were analysed per mouse, and five mice were analysed per group in four replicate experiments. The percentages of epithelial cells expressing Ki67 (Fig. 2j and Extended Data Fig. 6e) , TUNEL (Fig. 2k) and Krt12 (Fig. 3a, b) were determined by counting the number of positive cells among the total number of DAPI-positive corneal epithelial cells using the techniques described earlier. Comparisons between the Abcb5 wild-type and Abcb5 knockout mice were performed using the unpaired t-test. The results of transplantation experiments were compared using the analysis of variance (ANOVA) test. Differences with P , 0.05 were considered statistically significant. For preparation of murine cornea whole mounts used for BrdU and Abcb5 immunostaining, whole mouse eyes with lids attached were enucleated, rinsed in PBS and immediately fixed in 4% PFA overnight at room temperature. Fixed eyes were washed in PBS, the globe was bisected under a dissecting microscope in the nasal/temporal axis and the lids were removed. The posterior half of the eye was removed, leaving the cornea, limbus and part of the sclera intact. Relief cuts (7-10) were made from the corneal side and also from the scleral side to allow the limbus to lie as flat as possible. Throughout the dissection care was taken to handle the cornea and limbus as little as possible in order to retain anatomical integrity. To stain whole mount tissue for BrdU, tissue was placed on a rocker in 2 N HCl for 30 min, followed by 20 min in 0.1 M sodium borate. Two rinses in PBS were followed by 1 h in blocking buffer (25 ml 250 mg BSA, 2.5 ml 103 PBS, 1.5 ml goat serum, 75 ml Triton X-100, distilled H 2 O). Two more PBS rinses were followed by overnight incubation with the following primary antibodies: rabbit anti-ABCB5 antibody (NBP1-77687, Novus) and biotinylated mouse anti-BrdU antibody (51-75512x, BD Pharmingen). Next, after two PBS rinses, tissue was incubated in blocking buffer for 15 min, washed twice in PBS, and incubated with secondary antibodies for 1 h (Alexa Fluor546 goat antirabbit and APC Streptavidin). Two more PBS rinses were followed by 5 min of DAPI incubation and two further PBS rinses. Tissue was then mounted on slides (Immu-Mount; Thermo-electron Incorporated) with spacers to preserve the morphology (Avery laser labels, 5,262 with holes punched for tissue) and subsequently coverslipped. Confocal microscopy was conducted on an inverted laser scanning confocal microscope system (FV1000, Olympus) with an automated stage (Prior Scientific) with 320 (RI 0.85) and 360 (RI 1.42) objectives. Detection of palisades of Vogt and ABCB5 confocal microscopy. Optical coherence tomography (OCT) imaging of human corneal rims was performed with a prototype system as described previously by Lathrop et al.
24
. In brief, globes were punctured in several areas before the overnight fixation in 4% PFA. The following day, the tissue was washed and kept in PBS until ready to be embedded and sectioned. Prior to sectioning, the globes were scanned with a modified Bioptigen spectral-domain OCT system (Bioptigen; SuperLum) in order to define limbal regions containing defined palisade structures (Extended Data Fig. 1c-j) . These palisade-containing regions were marked with a surgical pen (Extended Data Fig.  1c ). Corneal and limbal tissues were then dissected from the marked areas (1 cm wide, extending 1 cm into the cornea and 1 cm into the sclera, see Extended Data  Fig. 1i, j) and sunk in a sucrose solution (15%, then 30%) in order to preserve the tissue structure during embedding. Tissue sections were placed in moulds surrounded by cooled (4 uC) OCT compound (Tissue-Tek, Sakura Finetek USA) and frozen in liquid nitrogen. Thirty-micrometre palisade-containing sections were cut on a cryostat refrigerated microtome and placed on slides (Fisher Superfrost, Thermo Fisher Scientific). Prior to immunolabelling, slides were washed in distilled water 33 15 min and once in NaBH 4 (1 mg ml
21
) for 10 min, and permeabilized with blocking buffer (13 PBS, 1% BSA, 0.3% Triton X-100, 6% donkey serum) for 1 h at room temperature. Slides were subsequently incubated in the dark at room temperature for 1 h with anti-ABCB5 monoclonal antibody (clone 3C2-1D12) diluted in dilution buffer (13 PBS, 1% BSA) and washed 33 5 min each in blocking buffer. Alexa Fluor546 donkey anti-mouse antibody dissolved in dilution buffer was applied for 1 h at room temperature. Subsequently, three washes of blocking buffer were applied for 5 min each, followed by nuclear staining, washing 23 5 min in 13 PBS and mounting with Immu-Mount (Thermo Electron Corporation). Slides were examined by confocal microscopy conducted on an inverted laser scanning confocal microscope system (FV1000, Olympus) with an automated stage (Prior Scientific) using 320 oil (RI 0.85) and 360 (RI 1.42) objectives. The three-dimensional display of reconstructed stacks is available as Supplementary Video 3. Antibodies. The following primary antibodies were used in flow cytometry experiments. Rabbit polyclonal anti-p63a antibody (H-129, sc-8344, Santa Cruz), rabbit polyclonal anti-p40 (DNp63) antibody (ABX-144A, Imgenex), mouse monoclonal anti-ABCB5 antibody (clone 3C2-2D12) 6 , goat polyclonal anti-cytokeratin 12 antibody (L15, sc-17101, Santa Cruz), rabbit polyclonal anti-Pax6 antibody (PRB-278P, Covance), rabbit polyclonal IgG isotype control antibody (ab27478, Abcam), mouse IgG1k isotype control antibody (clone X40, BD Biosciences), and goat IgG isotype control antibody (sc-3887, Santa Cruz). The secondary antibodies were goat antimouse FITC (F2012, Sigma-Aldrich), Alexa 647 goat anti-rabbit IgG (A21244, Invitrogen) and Dylight 649 donkey anti-goat (Jackson ImmunoResearch). For histopathology and immunohistochemical analyses, the following antibodies were used. Mouse monoclonal anti-ABCB5 (clone 3C2-1D12) 6 and rabbit antibody against p63a at 1:75 dilution (H-129, sc8344, Santa Cruz) followed by the appropriate secondary antibodies obtained from Jackson ImmunoResearch: FITC-donkey anti-rabbit (711-095-152) at 1:75 dilution or Alexa Fluor594 goat anti-mouse (115-515-062) at 1:250 dilution. In all cases, the isotype-matched antibodies rabbit IgG (550875, BD Pharmingen) and mouse IgG1k isotype control antibody (clone X40, BD Biosciences) served as controls. Further antibodies used for histopathology and immunohistochemical analyses were as follows. Rabbit anti-ABCB5 antibody at 1:250 dilution (NBP1-50547, Novus), human anti-ABCB5 extracellular loopassociated peptide monoclonal antibody (clone 3B9, 5 mg ml 21 ), rabbit polyclonal anti-Pax6 at 1:300 dilution (PRB-278P, Covance), goat anti-cytokeratin 12 (L15) at 1:50 dilution (sc17101, Santa Cruz), rabbit anti-human cytokeratin 12 (H-60, sc-25722), rabbit anti-cytokeratin 14 (AF64) at 1:1,000 dilution (PRB-155P, Covance), rabbit anti-Ki67 at 1:200 dilution (ab66155, Abcam), biotinylated BrdU antibody (51-75512, Pharmingen), followed by the appropriate secondary antibodies obtained from Jackson ImmunoResearch: donkey anti-goat Alexa Fluor488 at 1:250 dilution (705-545-003), donkey anti-rabbit Alexa Fluor594 at 1:20 dilution (711-585-152), goat anti-rabbit DyLight 549 at 1:250 dilution (111-504-144), or Cy3-donkey antirabbit at 1:250 dilution (711-165-152). Appropriate isotype-matched antibodies (rabbit IgG (550875, BD Pharmingen) and goat IgG (sc2028, Santa Cruz)) served as negative controls. Additional primary antibodies included rat anti-mouse Ly-6G 1:100 dilution (550291, BD Biosciences), rat anti-mouse F4/80 1:200 dilution (RM2900, Abcam), rat anti-mouse CD45R 1:25 dilution (550286, BD Biosciences), rabbit anti-CD3 1:100 dilution (5690, Abcam), rat IgG isotype control (559073, BD Pharmingen) and rabbit IgG isotype control (NB810-56910, Novus). Secondary antibodies were Alexa Fluor555 goat anti-rat at 1:250 dilution and Alexa Fluor594 goat anti-rabbit IgG at 1:250 dilution (A21434 and A11037 respectively, Life Technologies). Eyes from C57BL/6J mice taken 24 h post-infection with 500 colony forming units (c.f.u.) of Staphylococcus aureus and from normal C57BL/6J spleen and lymph nodes were used as positive controls for the reported inflammation marker expression studies. The fully human ABCB5 extracellular-loop-associated peptide-targeted IgG1 monoclonal antibody 3B9 was generated by Pfizer Centers for Therapeutic Innovation (CTI) during a collaboration with Boston Children's Hospital using screening of a human scFv phage display library for selection of LETTER RESEARCH binders to biotin-peg2-ABCB5 peptide (RFGAYLIQAGRMTPEG; UniProt accession Q2M3G0), followed by sequence analysis and human IgG1 conversion. The monoclonal antibody 3B9 binds to human ABCB5 peptide (RFGAYLIQAGRMT PEG; UniProt accession Q2M3G0) and mouse Abcb5 peptide (RFGAYLIQAGRM MPEG; UniProt accession B5X0E4) at concentrations ,10 nM, with no significant binding at these concentrations to either scrambled peptide or peptide homologues associated with the related ABCB1 (RFGAYLVAHKLMSFED; UniProt accession P08183), ABCB4 (RFGAYLIVNGHMRFRD; UniProt accession P21439) or ABC B11 (RYGGYLISNEGLHFSY; UniProt accession O95342) proteins. FITC-conjugated ZyMax goat anti-human IgG (H1L) antibody product (817111) was purchased from Invitrogen. Cell viability assays. Human limbal epithelial cells were seeded on 96-well plates (15,000 per well, n 5 5 replicates) and treated for 48 h with either blocking concentrations 12 of anti-ABCB5 monoclonal antibody clone 3C2-1D12 (ref. 6) or equivalent concentrations of isotype control monoclonal antibody (clone MOPC31C, Sigma). Cell viability was determined by the CellTiter-Glo Luminescent Cell Viability Assay (Promega) according to the manufacturer's instructions. In additional viability assays employing conditions resembling those used for ABCB5
1 cell staining for cell isolation, human limbal epithelial cells were incubated on ice with 2 mg ml 21 of anti-ABCB5 monoclonal antibody clone 3C2-1D12 (ref. 6) or isotype control monoclonal antibody (clone MOPC31C, Sigma) for 30 min. After washing with PBS, cells were seeded on 96-well plate (15,000 per well, n 5 5 replicates) and grown at 37 uC for 48 h, followed by determination of cell viability as described earlier. Statistical differences between samples were determined using the unpaired t-test. A two-sided P value of P , 0.05 was considered significant. Corneal fragility assay. Experimental animals were anaesthetized with intraperitoneal injections of 70 mg kg 21 sodium pentobarbital. Under a stereomicroscope, a partial epithelial defect was created in both eyes by brushing with a wet Microsponge (Alcon) as described by Kao et al.
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. The animals were euthanized in a CO 2 chamber, and the corneas were removed and embedded in paraffin for histology. H&E-stained Abcb5 knockout and wild-type corneas were analysed for the presence or absence of epithelial defects and results were compared using the Fisher's exact test. A two-sided P value of P , 0.05 was considered significant. Corneal epithelial debridement. After anaesthesia with intraperitoneal injection of ketamine (120 mg kg 21 body weight; Hospira) and xylazine (10 mg kg 21 body weight; Burns Veterinary Supply), followed by topical application of one drop of 0.5% proparacaine eye drops (Akorn) into each eye, a 2 mm diameter epithelial wound was created by demarcating an area of the central cornea with a 2 mm trephine and removing the epithelium within the circle with a small scalpel, leaving the basement membrane intact. In each animal, the procedure was performed on the right eye. Ak-Spore Ophthalmic Ointment (bacitracin zinc, neomycin sulphate and polymyxin B sulphate; Akorn) was applied to both eyes immediately after wounding and then twice per day for the next 48 h to prevent corneal infection and dryness. Analgesia was provided by subcutaneous injections of Buprenex (Reckitt Benckiser Pharmaceuticals) every 12 h for 48 h post-operatively at the dose of 1 mg kg 21 . Wound healing was monitored as described previously 26 . Corneal tight junction integrity. Hutcheon et al. 27 described a functional assay of corneal epithelial cell tight junction integrity using LC-biotin, which does not penetrate through the epithelium in the presence of intact tight junctions, whereas defective tight junctions allow penetration through the epithelium and into the corneal stroma. Wild-type and Abcb5 knockout mice were assessed for corneal epithelial tight junctions using the LC-biotin staining method performed as described 28 . In brief, LC-biotin staining solution was prepared by dissolving 1 mg ml 21 EZ-Link-Sulfo-NHS-LC-Biotin (Pierce) in Hank's balanced salt solution (HBSS, Lonza) plus 2 mM MgCl 2 and 1 mM CaCl 2 . This solution was applied to the cornea of wild-type and knockout mice for 15 min at the time of euthanasia. Eyes were rinsed with PBS (Lonza), enucleated and placed in Tissue-Tek OCT (Sakura Finetek) for frozen sectioning. Sections of wild-type and knockout corneas were stained with FITC-streptavidin to detect the presence of LC-biotin. 1 limbal epithelial cells; (2) ABCB5 2 limbal epithelial cells; (3) unsegregated limbal epithelial cells; and (4) grafts containing no cells (fibrin gel carrier only). Twenty-four hours before transplantation, murine and human donor cells were seeded onto a fibrin carrier, which was prepared by dissolving fibrinogen and thrombin stock solutions (TISSUCOL-Kit Immuno, Baxter) in 1.1% NaCl and 1 mM CaCl 2 to a final concentration of 10 mg ml 21 fibrinogen and 3 IU ml 21 thrombin as described 29 .
On the day of transplantation, total LSCD was induced in anaesthetized recipient mice by removing the corneal and limbal epithelium with an Algerbrush II corneal rust ring remover with a 0.5 mm burr (AMBLER Surgical) 30 . Following induction of LSCD, recipient mice received fibrin gel carrier-based transplants that were secured via four subconjunctival sutures. Eyelids were sutured with 8-0 nylon sutures to keep the eyes closed. AkSpore Ophthalmic Ointment (bacitracin zinc, neomycin sulphate and polymyxin B sulphate; Akorn) was applied on both eyes immediately after wounding and then twice per day for the next 48 h to prevent corneal infection and dryness. Analgesia was provided by subcutaneous injections of 5-10 mg kg 21 Metacam (Boehringer Ingelheim Pharmaceuticals), given preoperatively and by subcutaneous injections of 0.05-0.1 mg kg 21 of Buprenex (Reckitt Benckiser Pharmaceuticals) every 12 h for 24 h post-operatively. In addition, after surgical recovery mice were also treated with anti-inflammatory Inflanefran Forte eye drops (Allergan) for the first 5 days, and then with 1% Avastin (Bevacizumab, Genentech) eye drops daily for 5 days. Slit lamp examination was performed weekly until euthanasia. Eyes were enucleated postmortem and fixed in 10% buffered formalin for methacrylate embedding (Technovit, Heraeus Kulzer) or snap-frozen in Tissue-Tek OCT (Sakura Finetek). Confocal and multiphoton microscopic analysis of corneas. For whole corneal imaging, animals were euthanized and their eyes carefully enucleated. The eyes were then mounted using cyanoacrylate glue with the cornea facing up. Whole corneal imaging was performed using a custom-built video-rate laser-scanning confocal and multiphoton microscope with a custom femtosecond laser supply based on systems described by Veilleux et al.31 and Wang et al.32). In brief, a 1,550 nm turnkey fibre-based laser (Calmar Laser) with a 5 MHz pulse repetition rate and 360 fs pulse width was frequency doubled using a bismuth borate (BiBO) crystal with an AR1550/775nm coating (Newlight Photonics) to generate ,7.5 mW at the focal plane. Corneal layers were imaged using confocal reflectance with a quarter wave plate and an avalanche photodiode module (Hamamatsu) to collect backscattered signal. To further probe the structural elements of the cornea, second harmonic generation of collagen fibrils was collected using a PMT and a 390/40 nm band pass filter (Semrock). The apex of each cornea was imaged using a 360 1.0 NA objective (Olympus) at 15 frames per second with 1 mm steps from the surface of the cornea through the basal epithelial layers. Statistical analysis. We established a provisional number of mice per cohort for the pilot phase of a particular experiment based on initial feasibility considerations with regard to availability of cell graft material, and, if the data were suggestive of a significant difference, we calculated the numbers of mice needed for a repeat experiment to establish statistical significance, or not. There was no exclusion of samples or animals from the analysis. The investigators were blinded when assessing experimental outcomes. In gene knockout analyses, animals were allocated to experimental groups based on their Abcb5 knockout or Abcb5 wild-type status. For transplantation experiments all recipient animals were randomly assigned to their respective experimental groups. Two-sided tests were used in the statistical analyses. Appropriate statistical tests were used for all data sets depicted in the figures, with data meeting the assumptions of the tests. Variations within each group of data were estimated and similar between statistically compared groups. *P , 0.05, **P , 0.01 and ***P , 0.001. . Serial cross-sections of the biopsies were stained with either H&E, isotype control monoclonal antibody, or ABCB5 moncolonal antibody. ABCB5 staining in the limbal epithelium of donor 1 reveals nests of ABCB5-positive cells, whereas ABCB5-positivity is reduced in the limbal epithelium of patient 1. Photographs of immunofluorescent staining are montages of sequential photos at 320 magnification. In these studies, equal-sized biopsies were recovered from a portion of the patient and donor limbus, frozen, and sectioned to produce eight sequential sections. All epithelial cells were counted in each section. A total of 2,031 and 2,051 epithelial cells were counted in patient 1 and donor 1, respectively. b, Limbal biopsies were obtained from a patient (patient 2) with an autoimmune corneal melt, peripheral ulcerative keratitis, and partial limbal stem cell deficiency before receiving a kerato-limbal autograft from the patient's normal contralateral eye (donor 2). Serial sections of the biopsies were stained with either H&E, isotype control monoclonal antibody, or ABCB5 monoclonal antibody. ABCB5 positivity was present in the basal layer of the limbal epithelium of donor 2, while a dramatically reduced epithelial layer and no ABCB5 staining was observed in the limbus of patient 2. Photographs of immunofluorescent staining are montages of sequential photos at 320 magnification. In these studies, equal-sized biopsies were recovered from a portion of the patient and donor limbus, frozen, and sectioned to produce eight sequential sections. All epithelial cells were counted in each section. A total of 563 and 2,662 epithelial cells were counted in patient 2 and donor 2, respectively. Patient 2 had a reduced number of epithelial cells due to the extensive damage from chronic autoimmunity. c, LSCD patient information. *Donor 1: cadaveric donor; **Donor 2: autologous transplant from contralateral eye. KLAL, kerato-limbal allograft (limbal tissue was harvested from donor eye); KLAU, kerato-limbal autograft (part of limbal tissue was resected from uninjured contralateral eye); OD, right eye; PKP, penetrating keratoplasty; PUK, peripheral ulcerative keratitis.
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Extended Data Figure 4 | Functional evaluation of Abcb5 knockout versus wild-type mice. a, Increased corneal fragility in Abcb5 knockout mice. H&E-stained sections of wild-type (WT) and Abcb5 knockout (KO) corneas collected immediately after brushing with a wet Microsponge were examined for the presence or absence of epithelial defects. Only 33% of wild-type animal-derived cornea sections exhibited small epithelial defects (,25% of epithelium), whereas 100% of Abcb5 knockout cornea sections exhibited significant epithelial injury (n 5 3 mice per group, 25 sections per mouse, Fisher's exact test: P , 0.001). b-e, Wound healing following corneal epithelial debridement of wild-type and Abcb5 knockout mice. b, The area to be debrided was marked with a 2 mm trephine and the epithelium was removed with a small scalpel. c, DAPI-stained cross-section of the cornea immediately following central epithelial debridement depicting the wound margins and exposed central corneal stroma. Image is a montage of sequential photos at 310 magnification. d, Corneal epithelial wound closure was monitored at 1, 24, and 48 h post-debridement via fluorescein staining. e, Wound closure rates were not significantly different between wild-type and Abcb5 knockout mice (summary of n 5 2 replicate experiments, n 5 4 mice per group, unpaired t-test, P 5 not significant). f, Reduced re-epithelialization of wounded corneas in Abcb5 knockout mice. Representative DAPI-stained composite corneal cross sections of wild-type (left) and Abcb5 knockout (right) mice 48 h after a corneal epithelial debridement wound, demonstrating a reduced number of epithelial cells in Abcb5 knockout mice. The white dashed line demarcates the epithelium from stroma; the white box indicates area shown at 320 magnification (montage pictures are at 310 magnification); white lines demarcate the area in which epithelial cells were counted. Epithelial cells were counted within the standardized area in at least three consecutive composite cross sections in three replicate mice per group in two separate experiments (aggregate data shown in Fig. 2i) . g, Increased apoptosis in wounded corneas of Abcb5 knockout mice. Representative TUNEL-stained composite corneal cross-sections of wild-type (left) and Abcb5 knockout (right) mice 48 h after a corneal epithelial debridement wound, demonstrating increased numbers of apoptotic cells in Abcb5 knockout mice. Areas defined by the white box are shown at 320 magnification (montage pictures at 310 magnification). The number of TUNEL-positive epithelial cells was counted, and the data from two replicate experiments in n 5 2 mice are summarized in Fig. 2k . Error bars indicate s.e.m. NS, not significant.

